Multivariable analysis of variables in Table 4 (P < .1)
| . | Estimate . | SE . | z value . | Pr (>|z|) . | OR . | 95% CI (for OR) . |
|---|---|---|---|---|---|---|
| Intercept | −2.78 | 0.81 | −3.41 | 0.0006 | 0.06 | 0.01-0.26 |
| r/r (vs newly diagnosed) | 1.43 | 0.73 | 1.97 | 0.0485 | 4.19 | 1.13-21.12 |
| Responder (vs nonresponder) | −1.28 | 0.65 | −1.98 | 0.0473 | 0.28 | 0.07-0.93 |
| Decitabine (5 vs 10 d) | 0.25 | 0.69 | 0.36 | 0.7194 | 1.28 | 0.32-5.16 |
| HMA (azacitidine vs 10 d) | 1.78 | 0.8 | 2.23 | 0.0255 | 5.92 | 1.25-30.19 |
| . | Estimate . | SE . | z value . | Pr (>|z|) . | OR . | 95% CI (for OR) . |
|---|---|---|---|---|---|---|
| Intercept | −2.78 | 0.81 | −3.41 | 0.0006 | 0.06 | 0.01-0.26 |
| r/r (vs newly diagnosed) | 1.43 | 0.73 | 1.97 | 0.0485 | 4.19 | 1.13-21.12 |
| Responder (vs nonresponder) | −1.28 | 0.65 | −1.98 | 0.0473 | 0.28 | 0.07-0.93 |
| Decitabine (5 vs 10 d) | 0.25 | 0.69 | 0.36 | 0.7194 | 1.28 | 0.32-5.16 |
| HMA (azacitidine vs 10 d) | 1.78 | 0.8 | 2.23 | 0.0255 | 5.92 | 1.25-30.19 |
Pr, probability; SE, standard error.